CAPR241018C25000
- 0.25
- -0.09-26.47%
Capricor Therapeutics Newsroom
Capricor Therapeutics Call Volume Above Normal and Directionally Bullish
IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Here's How Much $100 Invested In Capricor Therapeutics 5 Years Ago Would Be Worth Today
Crude Oil Down Over 1%; Stitch Fix Shares Plummet
Capricor's FDA Plan for Deramiocel Lures Institutional Investors -- Market Talk
12 Health Care Stocks Moving In Wednesday's Intraday Session
Hewlett Packard Enterprise, Nvidia, Progress Software And Other Big Stocks Moving Higher On Wednesday
A Quick Look at Today's Ratings for Capricor Therapeutics(CAPR.US), With a Forecast Between $25 to $43
Capricor Therapeutics Is Maintained at Outperform by Oppenheimer
Express News | Capricor Therapeutics Inc. : Oppenheimer Raises Target Price to $43 From $15
Nvidia, Alibaba, Capricor Therapeutics, TSMC, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Health Care Stocks Fall as Novo Nordisk CEO Goes To Capitol Hill -- Health Care Roundup
Capricor Therapeutics Aims for DMD Treatment Approval and Expansion
Nippon Shinyaku Buys $15 Million of Capricor Therapeutics Stock
Sector Update: Health Care
Capricor Surges on Plans to Seek FDA Approval for Lead Asset
Cantor Fitzgerald Adjusts Capricor Therapeutics Price Target to $25 From $8, Maintains Overweight Rating; Shares Rise
Buy Rating Affirmed for Capricor Therapeutics on Promising DMD-cardiomyopathy Treatment Prospects
Why Capricor Therapeutics Stock Is Soaring Tuesday
Express News | Capricor Therapeutics Inc - Bla Filing for Deramiocel to Begin in October 2024